Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 8Active not recruiting 6Terminated 2Not yet recruiting 2Enrolling by invitation 2Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lymphedema 1Breast Neoplasms 1

Interventions

pembrolizumab 26Cisplatin 14Nivolumab 11Cyclophosphamide 11Carboplatin 11Paclitaxel 9Docetaxel 9Radiotherapy, Intensity-Modulated 8Radiotherapy 8Magnetic Resonance Spectroscopy 8Radiosurgery 7Radiation 7Fluorouracil 7Bevacizumab 7Leucovorin 6Irinotecan 6Gemcitabine 6Doxorubicin 6venetoclax 5olaparib 5enzalutamide 5Prednisone 5Pemetrexed 5Oxaliplatin 5Metformin 5Azacitidine 5fludarabine 4atezolizumab 4Taxes 4Surveys and Questionnaires 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Methods × 30 days × Clear all
NCT00376597 2026-05-18

Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection

Alliance for Clinical Trials in Oncology

Phase 3 Completed
568 enrolled 7 charts
Breast

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡